AAAAAA
Results: 101-125/1827
Authors:
Candotti, D
Mundy, C
Kadewele, G
Nkhoma, W
Bates, I
Allain, JP
Citation: D. Candotti et al., Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: High prevalence of HIV-1 subtype C and of markers of hepatitis Band C viruses, J MED VIROL, 65(1), 2001, pp. 1-5
Authors:
Van Damme, P
Leroux-Roels, G
Law, B
Diaz-Mitoma, F
Desombere, I
Collard, F
Tornieporth, N
Van Herck, K
Citation: P. Van Damme et al., Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults, J MED VIROL, 65(1), 2001, pp. 6-13
Authors:
Caussin-Schwemling, C
Schmitt, C
Stoll-Keller, F
Citation: C. Caussin-schwemling et al., Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro, J MED VIROL, 65(1), 2001, pp. 14-22
Authors:
Hadlock, KG
Gish, R
Rowe, J
Rajyaguru, SS
Newsom, M
Warford, A
Foung, SKH
Citation: Kg. Hadlock et al., Cross-reactivity and clinical impact of the antibody response to hepatitisC virus second envelope glycoprotein (E2), J MED VIROL, 65(1), 2001, pp. 23-29
Authors:
Sun, CA
Chen, HC
Lu, SN
Chen, CJ
Lu, CF
You, SL
Lin, SH
Citation: Ca. Sun et al., Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors, J MED VIROL, 65(1), 2001, pp. 30-34
Authors:
Puig-Basagoiti, F
Saiz, JC
Forns, X
Ampurdanes, S
Gimenez-Barcons, M
Franco, S
Sanchez-Fueyo, A
Costa, J
Sanchez-Tapias, JM
Rodes, J
Citation: F. Puig-basagoiti et al., Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C, J MED VIROL, 65(1), 2001, pp. 35-44
Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity
Authors:
Nakano, I
Fukuda, Y
Katano, Y
Toyoda, H
Hayashi, K
Kumada, T
Nakano, S
Citation: I. Nakano et al., Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity, J MED VIROL, 65(1), 2001, pp. 45-51
Authors:
Nagasaka, A
Takahashi, T
Sasaki, T
Takimoto, K
Miyashita, K
Nakamura, M
Wakahama, O
Nishikawa, S
Higuchi, A
Citation: A. Nagasaka et al., Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: Host genetic and virological study, J MED VIROL, 65(1), 2001, pp. 52-57
Authors:
Yu, ML
Chuang, WL
Chen, SCR
Dai, CY
Hou, C
Wang, JH
Lu, SN
Huang, JF
Lin, ZY
Hsieh, MY
Tsai, JF
Wang, LY
Chang, WY
Citation: Ml. Yu et al., Changing prevalence of hepatitis C virus genotypes: Molecular epidemiologyand clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan, J MED VIROL, 65(1), 2001, pp. 58-65
Authors:
Beby-Defaux, A
Maille, L
Chabot, S
Nassimi, A
Oriot, D
Agius, G
Citation: A. Beby-defaux et al., Fatal adenovirus type 7b infection in a child with Smith-Lemli-Opitz syndrome, J MED VIROL, 65(1), 2001, pp. 66-69
Authors:
Michel, D
Hohn, S
Haller, T
Jun, D
Mertens, T
Citation: D. Michel et al., Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein, J MED VIROL, 65(1), 2001, pp. 70-76
Authors:
Munoz, I
Gutierrez, A
Gimeno, C
Farga, A
Alberola, J
Solano, C
Prosper, F
Garcia-Conde, J
Navarro, D
Citation: I. Munoz et al., Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneicstem cell transplant, J MED VIROL, 65(1), 2001, pp. 77-84
Authors:
Schafer, P
Tenschert, W
Cremaschi, L
Schroter, M
Zollner, B
Laufs, R
Citation: P. Schafer et al., Area under the viraemia curve versus absolute viral load: Utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients, J MED VIROL, 65(1), 2001, pp. 85-89
Authors:
Bale, JF
Petheram, SJ
Robertson, M
Murph, JR
Demmler, G
Citation: Jf. Bale et al., Human cytomegalovirus alpha sequence and UL144 variability in strains frominfected children, J MED VIROL, 65(1), 2001, pp. 90-96
Authors:
Murgue, B
Cassar, O
Deparis, X
Citation: B. Murgue et al., Plasma concentrations of sVCAM-1 and severity of dengue infections, J MED VIROL, 65(1), 2001, pp. 97-104
Authors:
Nicholls, J
Kremmer, E
Meseda, CA
Mackett, M
Hahn, P
Gulley, ML
Brink, A
Swinnen, LJ
Greenspan, J
De Souza, Y
Grasser, F
Sham, J
Ng, MH
Arrand, JR
Citation: J. Nicholls et al., Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoiddiseases, J MED VIROL, 65(1), 2001, pp. 105-113
Authors:
Blaschke, S
Hannig, H
Buske, C
Kaup, FJ
Hunsmann, G
Bodemer, W
Citation: S. Blaschke et al., Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques, J MED VIROL, 65(1), 2001, pp. 114-120
Authors:
Sathar, MA
York, DF
Citation: Ma. Sathar et Df. York, Group 5: GBV-C/HGV isolates from South Africa, J MED VIROL, 65(1), 2001, pp. 121-122
Authors:
Schatz, O
Monini, P
Bugarini, R
Neipel, F
Schulz, TF
Andreoni, M
Erb, P
Eggers, M
Haas, J
Butto, S
Lukwiya, M
Bogner, JR
Yaguboglu, S
Sheldon, J
Sarmati, L
Goebel, FD
Hintermaier, R
Enders, G
Regamey, N
Wernli, M
Sturzl, M
Rezza, G
Ensoli, B
Citation: O. Schatz et al., Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: Multicentre study with multiple and novel assays, J MED VIROL, 65(1), 2001, pp. 123-132
Authors:
Portolani, M
Pecorari, M
Tamassia, MG
Gennari, W
Beretti, F
Guaraldi, G
Citation: M. Portolani et al., Case of fatal encephalitis by HHV-6 variant A, J MED VIROL, 65(1), 2001, pp. 133-137
Authors:
Casas, I
Palacios, GF
Trallero, G
Cisterna, D
Freire, MC
Tenorio, A
Citation: I. Casas et al., Molecular characterization of human enteroviruses in clinical samples: Comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products, J MED VIROL, 65(1), 2001, pp. 138-148
Authors:
Marais, DJ
Best, JM
Rose, RC
Keating, P
Soeters, R
Denny, L
Dehaeck, CMC
Nevin, J
Kay, P
Passmore, JA
Williamson, AL
Citation: Dj. Marais et al., Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia, J MED VIROL, 65(1), 2001, pp. 149-154
Authors:
Terry, G
Ho, L
Londesborough, P
Cuzick, J
Mielzynska-Lohnas, I
Lorincz, A
Citation: G. Terry et al., Detection of high-risk HPV types by the Hybrid Capture 2 test, J MED VIROL, 65(1), 2001, pp. 155-162
Authors:
Boon, ACM
French, AMF
Fleming, DM
Zambon, MC
Citation: Acm. Boon et al., Detection of influenza A subtypes in community-based surveillance, J MED VIROL, 65(1), 2001, pp. 163-170
Authors:
Wareing, MD
Watson, JM
Brooks, MJ
Tannock, GA
Citation: Md. Wareing et al., Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza A vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice, J MED VIROL, 65(1), 2001, pp. 171-177